Study KBP-2020-CPHG Documenting New Cases of Primary Lung Cancer (PLC) Diagnosed in Respiratory Medicine Departments and Lung Cancer Units at General Hospitals From January 1st to December 31st 2020

Collège des Pneumologues des Hôpitaux Généraux

Status: Enrolling

Conditions: Lung Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT04402099

2019-A00943-54

Details and patient eligibility

About

Twenty years after KBP-2000-CPHG study and ten years after KBP-2010-CPHG study, the CPHG proposes to conduct a new epidemiological study on primary PLC in order to evaluate and analyze the changes that have occurred over the last decade.

Primary endpoint:

Estimate 1-year- and 5-year-mortality rates in patients with PLC.

Secondary endpoints:

• Describe PLC patient population managed by pulmonologists at French General Hospitals in 2020
• Describe PLC diagnostic and therapeutic management by pulmonologists at French General Hospitals in 2020 and compare them to KBP-2000-CPHG and KBP-2010-CPHG studies
• Estimate prognostic factors
• Compare patient and tumor characteristics to those observed for KBP-2010-CPHG and KBP-2000-CPHG studies
• Compare observed survival rates to those reported for KBP-2000-CPHG and KBP-2010-CPHG studies

Enrollment: 10,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Age ≥ 18 years
• Primary Lung Cancer histologically (or cytologically or presence of a mutation on liquid biopsy with compatible imaging) proven between January 1st and December 31st, 2020*
• Follow-up by a lung specialist at a General Hospital
• Oral informed consent * date of collected sample

Exclusion criteria

• Age < 18 years
• Secondary lung cancer
• Recurrence of same histological type PLC- left to the investigator discretion according to the clinic and the imagery
• Previous enrolment in the study
• Freedom deprived patient following a legal or administrative decision
• Patient unable to give his(her) consent